Daiichi Sankyo Co Ltd ADREigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 17.25 USD | 26,911 USD | 14,98 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.819.653.230 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Daiichi Sankyo Co Ltd ADR
Mitarbeiter 20.171
Handelsplatz PINK
Ticker Symbol DSNKY
IPO Datum -
Adresse Daiichi Sankyo Building A/B, Chuo, Japan, 103-8426
Webseite https://www.daiichisankyo.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Hiroyuki Okuzawa | President, CEO & Representative Director |
| 2 | Mr. Tomohiro Kodama | Senior Executive Officer, Head of Global Corporate Planning & Management and CFO |
| 3 | Tetsuya Ohira | Corporate Officer, Head of Business Transformation & CTO |
| 4 | Naoto Tsukaguchi | Senior Executive Officer, Head of Global Legal & IP, GC |
| 5 | Matt Allegrucci | Head of Global Compliance & Risk Management and Chief Compliance Officer |
| 6 | Mr. Takashi Matsumoto | Sr. Exec Ofcr, Chief Corp Affairs Ofcr, Head of Global Corp Affairs & HR, CHRO & Director |
| 7 | Mr. Joji Nakayama | Senior Adviser |
| 8 | Mr. Joseph Kenneth Keller | Head of Oncology Business Unit & Global Oncology Business and Director |
| 9 | Mr. Stuart Mackey J.D. | Global Head of Business Development & Director |
| 10 | Thierry Gruson | Head of Global Oncology Marketing |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.